m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0002)
Name |
Berberine
|
||||
---|---|---|---|---|---|
Synonyms |
Berberin; Umbellatine; UNII-0I8Y3P32UF; 0I8Y3P32UF; CHEBI:16118; EINECS 218-229-1; Berberal; BRN 3570374; ST055798; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; Berbamine sulphate acid; CHEMBL12089; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE
Click to Show/Hide
|
||||
Status | Phase 4 | [1] | |||
Structure |
|
||||
Formula |
C20H18NO4+
|
||||
InChI |
InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1
|
||||
InChIKey |
YBHILYKTIRIUTE-UHFFFAOYSA-N
|
||||
PubChem CID | |||||
TTD Drug ID | |||||
DrugBank ID |
Full List of m6A Targets Related to This Drug
Fibrinogen alpha chain (FGA)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Drug Response by This Target Gene | [2] | |||
Response Summary | m6A plays an important role in cisplatin induced acute kidney injury and berberine alleviates this process. Cisplatin induced an increase in Slc12a1 protein levels and a decrease in Fibrinogen alpha chain (FGA) and Havcr1 protein levels. However, berberine pretreatment reversed these effects. | |||
Responsed Disease | Acute kidney failure | ICD-11: GB60 | ||
Cell Process | Metabolic processes | |||
Cell death | ||||
Cell apoptosis | ||||
In-vivo Model | This study investigated the N6-methyladenosine (m6A) methylome of kidneys from three mouse groups: C57 mice (controls), those with CI-AKI (injury group, IG), and those pretreated with berberine (treatment group, TG). | |||
Hepatitis A virus cellular receptor 1 (HAVCR1)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Drug Response by This Target Gene | [2] | |||
Response Summary | m6A plays an important role in cisplatin induced acute kidney injury and berberine alleviates this process. Cisplatin induced an increase in Slc12a1 protein levels and a decrease in FGA and Hepatitis A virus cellular receptor 1 (HAVCR1) protein levels. However, berberine pretreatment reversed these effects. | |||
Responsed Disease | Acute kidney failure | ICD-11: GB60 | ||
Cell Process | Metabolic processes | |||
Cell death | ||||
Cell apoptosis | ||||
In-vivo Model | This study investigated the N6-methyladenosine (m6A) methylome of kidneys from three mouse groups: C57 mice (controls), those with CI-AKI (injury group, IG), and those pretreated with berberine (treatment group, TG). | |||
Solute carrier family 12 member 1 (SLC12A1)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Drug Response by This Target Gene | [2] | |||
Response Summary | m6A plays an important role in cisplatin induced acute kidney injury and berberine alleviates this process. Cisplatin induced an increase in Solute carrier family 12 member 1 (SLC12A1) protein levels and a decrease in FGA and Havcr1 protein levels. However, berberine pretreatment reversed these effects. | |||
Responsed Disease | Acute kidney failure | ICD-11: GB60 | ||
Cell Process | Metabolic processes | |||
Cell death | ||||
Cell apoptosis | ||||
In-vivo Model | This study investigated the N6-methyladenosine (m6A) methylome of kidneys from three mouse groups: C57 mice (controls), those with CI-AKI (injury group, IG), and those pretreated with berberine (treatment group, TG). | |||
References